Search results
Results from the WOW.Com Content Network
You can often tell the health of the stock market by the number and performance of initial public offerings, or IPOs. As 2022 has seen a bear market in the major averages, it's not surprising at ...
For premium support please call: 800-290-4726 more ways to reach us
This page was last edited on 3 February 2024, at 22:53 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Although no clinical development took place, Axovant held its IPO in June 2015 and raised $315 million, [4] the largest biotech IPO ever, [9] based on new phase IIB trials that were more promising. [10] The lock-up period against reselling stock was reduced to an unusually short 90 days for hedge funds that showed interest in the IPO. [11]
Monsanto merges with Pharmacia and Upjohn, [1] so the agricultural division became a wholly owned subsidiary of the "new" Pharmacia. 2000: Corporation: Pharmacia spins off its Monsanto subsidiary into a new company, [1] the "new Monsanto" - which then raises $700 million in a new IPO. [32] The "new Monsanto" is legally distinct from the old pre ...
The IPO raised $604.3 million and eclipsed the $373 million raised by Allogene Therapeutics in October, which is the largest biotech since Axovant Sciences' $363 million IPO in 2015.
Cetus Corporation was one of the first biotechnology companies. [1] It was established in Berkeley, California , in 1971, but conducted most of its operations in nearby Emeryville . Before merging with Chiron Corporation in 1991 (now a part of Novartis ), it developed several significant pharmaceutical drugs as well as a revolutionary DNA ...
The IPO market is off to a lackluster start in 2019, with one culprit being the federal government shutdown — which halted public listings. 2018 was a better year for IPOs, with 190 companies ...